Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ablad B., Brogård M., Ek L. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh) 1967;25:9–40. [PubMed] [Google Scholar]
- Johnsson G., Norrby A., Sölvell L. Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses. Acta Pharmacol Toxicol (Copenh) 1967;25:95–105. doi: 10.1111/j.1600-0773.1967.tb03000.x. [DOI] [PubMed] [Google Scholar]
- Kofi Ekue J. M., Lowe D. C., Shanks R. G. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Br J Pharmacol. 1970 May;38(3):546–553. doi: 10.1111/j.1476-5381.1970.tb10596.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner P., Hill R. C. A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs. 1968 Jul-Aug;8(4):268–271. doi: 10.1002/j.1552-4604.1968.tb00104.x. [DOI] [PubMed] [Google Scholar]
